Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02407704Phase 4Completed
Phase 4, randomised trial (2 arms). Primary endpoint: Number of Participants Experiencing Remission at 12 weeks. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02407704.